These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22086717)

  • 1. Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway.
    Zheng R; Deng Y; Chen Y; Fan J; Zhang M; Zhong Y; Zhu R; Wang L
    Phytother Res; 2012 Jun; 26(6):892-8. PubMed ID: 22086717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
    Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
    Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside-Rg1 protects podocytes from complement mediated injury.
    Zhang MH; Fan JM; Xie XS; Deng YY; Chen YP; Zhen R; Li J; Cheng Y; Wen J
    J Ethnopharmacol; 2011 Sep; 137(1):99-107. PubMed ID: 21600971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of CXCL12 performs a protective effect on C5b-9-induced injury in podocytes.
    Sha W; Shen L; Zhou L; Xu D; Yang J; Lu G
    Int Urol Nephrol; 2018 Aug; 50(8):1535-1544. PubMed ID: 29508174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy protects podocytes from sublytic complement induced injury.
    Lv Q; Yang F; Chen K; Zhang Y
    Exp Cell Res; 2016 Feb; 341(2):132-8. PubMed ID: 26883468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cordycepin protects podocytes from injury mediated by complements complex C5b-9].
    Hong T; Cui LK; Wen J; Zhang MH; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):173-8, 227. PubMed ID: 25924424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular response to injury in membranous nephropathy.
    Nangaku M; Shankland SJ; Couser WG
    J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.
    Wang H; Liu H; Cheng H; Xue X; Ge Y; Wang X; Yuan J
    Am J Nephrol; 2024; 55(3):345-360. PubMed ID: 38330925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV relieves passive heymann nephritis and podocyte injury by suppressing the TRAF6/NF-κb axis.
    Ma Y; Hu Y; Ruan Y; Jiang X; Zhao M; Wang Y; Ke Y; Shi M; Lu G
    Ren Fail; 2024 Dec; 46(2):2371992. PubMed ID: 39082739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Podocyte depletion in children with hepatitis B virus-associated membranous nephropathy].
    Zhang Y; Zhou JH; Wang HT
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):344-8. PubMed ID: 17697619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
    Fujino T; Hasebe N
    BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy.
    Liu WJ; Li ZH; Chen XC; Zhao XL; Zhong Z; Yang C; Wu HL; An N; Li WY; Liu HF
    Sci Rep; 2017 Aug; 7(1):8643. PubMed ID: 28819100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
    Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
    Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus.
    Ahmed MS; Hou SH; Battaglia MC; Picken MM; Leehey DJ
    Am J Kidney Dis; 2007 Dec; 50(6):1028-32. PubMed ID: 18037104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via alpha3beta1 integrin upregulation and integrin-linked kinase inhibition.
    Chen J; Gui D; Chen Y; Mou L; Liu Y; Huang J
    Biochem Pharmacol; 2008 Sep; 76(6):796-804. PubMed ID: 18652804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
    Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
    J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte antigens and glomerular disease.
    Ronco P; Debiec H
    Nephron Exp Nephrol; 2007; 107(2):e41-6. PubMed ID: 17726340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
    Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
    Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.